• Study Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia Denmark France Germany Italy +3

  • Study of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Belgium France Germany Italy Poland Romania +1

  • Title: Evaluation of lorazepam, pregabalin, and olanzapine in treating agitated behavior in dementia patients who did not respond to standard treatments

    Recruiting

    3 1 1
    Investigated Drugs:
    The Netherlands

  • Study on Sumatriptan and Rimegepant for Treating Nitroglycerin-Induced Headaches in Patients with Episodic Migraine

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on the Safety and Effects of NSC001 and Trospium Chloride for Patients with Mild to Moderate Alzheimer’s Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia Germany Italy

  • Study on Colchicine and Tiemonium Methylsulphate for Reducing Atherosclerosis in Cancer Patients Undergoing Immune Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on [18F]Tetrafluoroborate PET/CT for Detecting Thyroid Cancer in Patients with Differentiated Thyroid Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    The Netherlands

  • Study of ETX-19477 for Patients with Advanced Solid Tumors After Standard Treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain

  • Study on Encorafenib, Binimetinib, Cemiplimab, and Fianlimab for Patients with BRAF-Mutated Melanoma and Brain Metastases

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Spain

  • Study on MB-CART2219.1 for Adults and Children with Relapsed or Refractory B-cell Malignancies

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

powered by